Eliane Fuseau

1.4k total citations
40 papers, 1.0k citations indexed

About

Eliane Fuseau is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Eliane Fuseau has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 8 papers in Pediatrics, Perinatology and Child Health and 7 papers in Surgery. Recurrent topics in Eliane Fuseau's work include Migraine and Headache Studies (12 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Olfactory and Sensory Function Studies (5 papers). Eliane Fuseau is often cited by papers focused on Migraine and Headache Studies (12 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Olfactory and Sensory Function Studies (5 papers). Eliane Fuseau collaborates with scholars based in France, United Kingdom and United States. Eliane Fuseau's co-authors include Lewis B. Sheiner, David Critchley, Emilio Perucca, James C. Cloyd, Valérie Cosson, D. J. Sumner, Julien Mamet, Olivier Pétricoul, P. Rosenzweig and Tim Ibbotson and has published in prestigious journals such as Journal of Clinical Oncology, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Eliane Fuseau

40 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eliane Fuseau France 17 540 249 213 162 117 40 1.0k
Luigi Francesco Iannone Italy 20 417 0.8× 147 0.6× 228 1.1× 174 1.1× 288 2.5× 73 1.1k
N. Baber United Kingdom 18 491 0.9× 67 0.3× 324 1.5× 308 1.9× 65 0.6× 34 1.1k
Willem K. Amery Belgium 22 474 0.9× 45 0.2× 183 0.9× 219 1.4× 168 1.4× 65 1.2k
Marleen Depré Belgium 16 190 0.4× 45 0.2× 301 1.4× 94 0.6× 131 1.1× 43 1.2k
Ramesh Boinpally United States 19 428 0.8× 57 0.2× 179 0.8× 235 1.5× 219 1.9× 86 1.2k
Kerry L. Dechant 7 185 0.3× 37 0.1× 144 0.7× 158 1.0× 140 1.2× 10 764
R Stoltz United States 19 159 0.3× 38 0.2× 329 1.5× 110 0.7× 337 2.9× 31 1.2k
Niels‐Erik Larsen Denmark 20 384 0.7× 115 0.5× 77 0.4× 78 0.5× 171 1.5× 44 1.1k
Andrew C. Nelsen United States 16 187 0.3× 30 0.1× 203 1.0× 134 0.8× 79 0.7× 40 951
Morgan Feely United Kingdom 13 202 0.4× 210 0.8× 102 0.5× 41 0.3× 975 8.3× 18 1.7k

Countries citing papers authored by Eliane Fuseau

Since Specialization
Citations

This map shows the geographic impact of Eliane Fuseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliane Fuseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliane Fuseau more than expected).

Fields of papers citing papers by Eliane Fuseau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eliane Fuseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliane Fuseau. The network helps show where Eliane Fuseau may publish in the future.

Co-authorship network of co-authors of Eliane Fuseau

This figure shows the co-authorship network connecting the top 25 collaborators of Eliane Fuseau. A scholar is included among the top collaborators of Eliane Fuseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eliane Fuseau. Eliane Fuseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guéret, Pierre, S. Combe, Eliane Fuseau, et al.. (2016). Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study. European Journal of Clinical Pharmacology. 73(1). 15–28. 3 indexed citations
3.
Zisowsky, Jochen, Eliane Fuseau, Shirin Bruderer, Andreas Krause, & Jasper Dingemanse. (2014). Challenges in collecting pharmacokinetic and pharmacodynamic information in an intensive care setting: PK/PD modelling of clazosentan in patients with aneurysmal subarachnoid haemorrhage. European Journal of Clinical Pharmacology. 70(4). 409–419. 5 indexed citations
4.
Guéret, Pierre, et al.. (2013). EP42675, a synthetic parenteral dual‐action anticoagulant: pharmacokinetics, pharmacodynamics, and absence of interactions with antiplatelet drugs. Journal of Thrombosis and Haemostasis. 12(1). 24–33. 2 indexed citations
5.
Falcão, Amílcar, Eliane Fuseau, Teresa Nunes, Luís Almeida, & Patrício Soares‐da‐Silva. (2011). Pharmacokinetics, Drug Interactions and Exposure-Response Relationship of Eslicarbazepine Acetate in Adult Patients with Partial-Onset Seizures. CNS Drugs. 26(1). 79–91. 26 indexed citations
6.
Fuseau, Eliane, et al.. (2010). Supporting the recommended paediatric dosing regimen for rufinamide in Lennox–Gastaut syndrome using clinical trial simulation. Journal of Pharmacokinetics and Pharmacodynamics. 37(1). 99–118. 11 indexed citations
7.
Perucca, Emilio, James C. Cloyd, David Critchley, & Eliane Fuseau. (2008). Rufinamide: Clinical pharmacokinetics and concentration–response relationships in patients with epilepsy. Epilepsia. 49(7). 1123–1141. 168 indexed citations
8.
Fuseau, Eliane, et al.. (2007). Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling. Journal of Pharmaceutical Sciences. 96(12). 3444–3456. 10 indexed citations
9.
Christensen, Michael L., et al.. (2004). Pharmacokinetics of Sumatriptan Nasal Spray in Children. The Journal of Clinical Pharmacology. 44(4). 359–367. 11 indexed citations
10.
Fuseau, Eliane, et al.. (2003). Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients. European Journal of Clinical Pharmacology. 59(11). 783–790. 33 indexed citations
11.
Nestorov, Ivan, Gordon Graham, Stephen B. Duffull, et al.. (2001). Modeling and Simulation for Clinical Trial Design Involving a Categorical Response: A Phase II Case Study with Naratriptan. Pharmaceutical Research. 18(8). 1210–1219. 27 indexed citations
12.
Christensen, Michael L., et al.. (2001). Pharmacokinetics of Naratriptan in Adolescent Subjects with a History of Migraine. The Journal of Clinical Pharmacology. 41(2). 170–175. 17 indexed citations
13.
Cox, Eugène, et al.. (1999). A Population Pharmacokinetic–Pharmacodynamic Analysis of Repeated Measures Time-to-Event Pharmacodynamic Responses: The Antiemetic Effect of Ondansetron. Journal of Pharmacokinetics and Biopharmaceutics. 27(6). 625–644. 46 indexed citations
14.
Cosson, Valérie & Eliane Fuseau. (1999). Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development: II. From Healthy Subjects to Phase 2 Dose Ranging in Patients. Journal of Pharmacokinetics and Biopharmaceutics. 27(2). 149–171. 25 indexed citations
15.
Mamet, Julien, et al.. (1998). Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration. European Journal of Pharmaceutical Sciences. 6(2). 99–104. 104 indexed citations
16.
Williams, Pauline, et al.. (1997). 5-21-24 A study to investigate the central effects of naratriptan in man. Journal of the Neurological Sciences. 150. S306–S306. 2 indexed citations
17.
Fuseau, Eliane, et al.. (1997). 3-21-02 Naratriptan oral pharmacokinetic-pharmacodynamic modelling of pain relief in migraine subjects. Journal of the Neurological Sciences. 150. S167–S167. 1 indexed citations
18.
Fuseau, Eliane, et al.. (1997). 1-21-09 Naratriptan oral pharmacokinetics in migraine subjects. Journal of the Neurological Sciences. 150. S33–S33. 3 indexed citations
19.
Chosidow, O., C. Dubruc, Philippe Danjou, et al.. (1996). Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine. European Journal of Clinical Pharmacology. 50(4). 327–333. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Francesco Iannone Breakdown of academic impact, for papers by N. Baber Breakdown of academic impact, for papers by Willem K. Amery Breakdown of academic impact, for papers by Marleen Depré Breakdown of academic impact, for papers by Ramesh Boinpally Breakdown of academic impact, for papers by Kerry L. Dechant Breakdown of academic impact, for papers by R Stoltz Breakdown of academic impact, for papers by Niels‐Erik Larsen Breakdown of academic impact, for papers by Andrew C. Nelsen Breakdown of academic impact, for papers by Morgan Feely
Rankless by CCL
2026